Analysis of tumor (S100+) ROIs revealed significant overexpression of fibronectin and lower expression of 4-1BB and OX40L between the group with brain metastases (BM) versus the group without metastases (NM) (Table 3, Figures 2b, e, f). This evidence concerns the gene TNFSF4 and neoplasm.